LOGIN  |  REGISTER
Terns Pharmaceuticals
Astria Therapeutics

Neighbourly Pharmacy Announces Timing of First Quarter 2024 Earnings Release

TORONTO, July 13, 2023 /CNW/ - Neighbourly Pharmacy Inc. ("Neighbourly" or the "Company") (TSX: NBLY), Canada's largest and fastest growing network of community pharmacies, will release its financial results for the first quarter of fiscal 2024 prior to the market open on Tuesday, August 1, 2023. The release will be followed by a conference call at 8:30AM ET.

Participants may join Neighbourly's conference call by dialing 416-764-8650 or 1-888-664-6383 (ID: 59369825). The conference call will also be available via webcast using the Investor Relations section of the Company's website at https://investors.neighbourlypharmacy.ca/events-and-presentations.

For those unable to participate, playback will be made available an hour after the event at 416-764-8677 or 1-888-390-0541, utilizing passcode 369825#. The webcast of the call will also be archived and available on Neighbourly's website.

About Neighbourly Pharmacy Inc.

Neighbourly is Canada's largest and fastest growing network of community pharmacies. United by their patient first focus and their role as essential and trusted healthcare hubs within their communities, Neighbourly's pharmacies strive to provide accessible healthcare with a personal touch. Since 2015, Neighbourly has expanded its diversified national footprint to include 291 locations, reinforcing the Company's reputation as the industry's acquirer of choice.

Forward-Looking Statements

This press release contains forward-looking statements. When used in this news release, the word "will" and similar expressions, as they relate to Neighbourly, are intended to identify forward-looking statements. These forward-looking statements are subject to the inherent uncertainties in predicting future results and conditions. Forward-looking information is necessarily based on a number of opinions, assumptions and estimates that, while considered reasonable by Neighbourly as of the date of this press release, are subject to known and unknown risks, uncertainties, assumptions and other factors, many of which are beyond Neighbourly's control, including, without limitation, the risk factors and other matters set forth in Neighbourly's filings with the securities commissions or similar securities regulatory authorities in each of the provinces and territories of Canada. Neighbourly undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by law.

Assertio

Stock Quote

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page